Incyte (INCY) Cash & Equivalents (2010 - 2026)

Incyte's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $3.5 billion for Q1 2026.

• Quarterly Cash & Equivalents rose 78.25% year-over-year to $3.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 78.25% YoY) and the FY2025 annual result came in at $3.1 billion, up 83.54% from the prior year.
• Cash & Equivalents was $3.5 billion for Q1 2026 at Incyte, up from $3.1 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.5 billion in Q1 2026 and bottomed at $987.3 million in Q2 2024.
• A 5-year average of $2.5 billion and a median of $2.7 billion in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents sank 68.47% — and 2025, when it surged 98.01%.
• Incyte's Cash & Equivalents stood at $3.0 billion in 2022, then rose by 8.88% to $3.2 billion in 2023, then tumbled by 47.47% to $1.7 billion in 2024, then soared by 83.54% to $3.1 billion in 2025, then advanced by 11.73% to $3.5 billion in 2026.
• Business Quant data shows INCY's Cash & Equivalents at $3.5 billion in Q1 2026, $3.1 billion in Q4 2025, and $2.5 billion in Q3 2025.